Dr. Francisco Vega, MD

Dr. Vega practices at Mission Surgical Group in Riverside, California.

Dr. Vega's NPI, 1538422704, was assigned on June 21, 2012. Dr. Vega graduated from Meharry Medical College School of Medicine in 2012. Dr. Vega holds California license A130863.

Dr. Vega's primary practice is Mission Surgical Group, at 3660 Park Sierra Dr, Riverside, CA 92505 in Riverside County. The practice phone is (951) 278-8870.

Dr. Vega's primary practice is Mission Surgical Group in Riverside, California. Dr. Vega is also affiliated with Riverside Community Hospital. The medical group on file is Mission Surgical Clinic. Dmand AI also links Dr. Vega to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vega practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Vega's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Vega is licensed in California.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization and peripheral vascular disease among the conditions Dr. Vega treats.

CMS data shows 2,181 Medicare services from Dr. Vega across 31 procedure codes in 2024, for 337 Medicare patients. Medicare paid $814,683 for them.

CMS counts 337 Medicare patients who saw Dr. Vega in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vega's median patient age at 67, with 52% women.

In 2024, Dr. Vega wrote 913 Medicare Part D claims for 258 patients. 88% of them were for generic drugs. CMS names the drug for 849 of them, across 12 drugs with 11 or more claims each, at $75,524 in total drug cost. In 2023, CMS named 534 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Vega for performance year 2024, reported as part of a group. CMS counts 81 procedures of leg revascularization (restoring blood flow) by Dr. Vega, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Vega, published from 2012 to 2021. 2021 was the busiest year, with 13. The most frequent topics are Biomarkers, Tumor, Lymphoma, Large B-Cell, Diffuse and Immunohistochemistry. Dr. Vega has published most often in Mod Pathol. Dr. Vega's most frequent co-authors are Leonard Jeffrey Medeiros, MD, Izidore Lossos, MD and Roberto N. Miranda, MD.

CMS Open Payments shows 227 general payments to Dr. Vega from 30 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 66% of the total. Medtronic Vascular, Inc. paid the most, $3,337.

Dr. Vega graduated from Meharry Medical College School of Medicine in 2012.

Dr. Vega is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.